(Q39336473)

English

Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mannix LK

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Loder E

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Nett R

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Mueller L

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rodgers A

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hustad CM

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ramsey KE

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Skobieranda F

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

414-421

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Menstrual migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

The use of triptans in the management of menstrual migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Efficacy of oral naratriptan in the treatment of menstrually related migraine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Prevalence of migraine on each day of the natural menstrual cycle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Defining the relationship between ovarian hormones and migraine headache

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2007.01313.X

21 January 2018

Identifiers

10.1111/J.1468-2982.2007.01313.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39336473&oldid=1820638241"